FIELD: medicine; biotechnologies.
SUBSTANCE: adenoviral vector carrying in the genome structure a human lactoferrin gene, administer into an allantois of the 9-10 day chicken embryoses. The subsequent planting is performed by egg incubation at temperature of 37°C within 70-75 hours. Then allocate the recombinant protein from the allantoic liquid of a chicken embryos.
EFFECT: depression of expenses and obtaining simplification of the recombinant human lactoferrin.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING PERORAL VACCINE AGAINST RABIES VIRUS | 2010 |
|
RU2432963C1 |
| METHOD OF PREPARATION OF RECOMBINANT ADENOVIRUS OF BIRDS FOR VACCINATION AGAINST BIRDS FLU VIRUS H5N1 | 2006 |
|
RU2326943C1 |
| METHOD OF PREPARATION OF RECOMBINANT BIRDS VIRUS FOR VACCINATION AND GENETIC THERAPY | 2007 |
|
RU2326942C1 |
| METHOD OF INSERTION OF HETERODUPLEX DNA INTO GENOME OF ADENOVIRUS CELO AND RECOMBINANT ADENOVIRAL VECTOR CELO/PUC19 | 1992 |
|
RU2031122C1 |
| NON-INFECTIOUS FOR HUMAN ADENOVIRUS AS VECTOR FOR SUBSTITUTION GENETIC THERAPY OF ANGIOGENESIS DISORDER PROVIDING EFFECTIVE SYNTHESIS OF HUMAN ANGIOGENIN IN MAMMALIAN TRANSFECTED CELLS, METHOD FOR ANGIOGENESIS INDUCTION, METHOD FOR TREATMENT OF ISCHEMIC DISEASE, COMPOSITION FOR INDUCTION OF ANGIOGENESIS AND TREATMENT OF ISCHEMIC DISEASE | 2005 |
|
RU2321631C2 |
| METHOD FOR PREPARING ANTIGENS OF AVIAN ADENOVIRUSES | 2001 |
|
RU2217496C2 |
| IMMORTALISED BIRD CELL LINES FOR OBTAINING VIRUSES | 2004 |
|
RU2359999C2 |
| PHARMACEUTICAL COMPOSITION PRODUCING ANTIOXIDANT, ANTIMICROBIAL, ANTITOXIC HUMAN LACTOFERRIN PROTEIN, METHOD FOR PREPARING IT, AND METHOD OF THERAPY | 2012 |
|
RU2489168C1 |
| VACCINE AGAINST INFLUENZA TYPE A, INFLUENZA TYPE B AND COVID-19 | 2021 |
|
RU2751485C1 |
| PHARMACEUTICAL COMPOSITION FOR THERAPY OF ACUTE TOXIC CONDITIONS | 2012 |
|
RU2488406C1 |
